Ginkgo Bioworks HoldingsDNA
13F holders, Q1 2025 (March 31)1holders −8
1new positions
0sold out
$0.33avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Ginkgo Bioworks Holdings Inc. (DNA) in their 13F filings, down 8 from Q3 2024. 1 opened new positions and 0 sold out. The largest holder was Boston Standard Wealth Management, LLC ($203K).
- Company
- Ginkgo Bioworks Holdings Inc.
- CUSIP
- 37611X100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $203K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q1 2025: 606,634 shares bought, net +606,634 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Boston Standard Wealth Management, LLC | 0.04% | New | 606,634 | $203K |
"% of holder's portfolio" is DNA's weight in each manager's 13F, not the share of Ginkgo Bioworks Holdings Inc. the manager owns.